• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

性类固醇及其抑制对骨骼生长和成熟的影响。

Impact of sex steroids and their suppression on skeletal growth and maturation.

作者信息

Boepple P A, Mansfield M J, Link K, Crawford J D, Crigler J F, Kushner D C, Blizzard R M, Crowley W F

机构信息

Department of Medicine, Massachusetts General Hospital, Boston.

出版信息

Am J Physiol. 1988 Oct;255(4 Pt 1):E559-66. doi: 10.1152/ajpendo.1988.255.4.E559.

DOI:10.1152/ajpendo.1988.255.4.E559
PMID:3052107
Abstract

Forty girls with central precocious puberty (CPP) were studied before and during 1-3 yr of luteinizing hormone-releasing factor (LHRH) agonist (LHRHa) administration to examine the impact of gonadal steroid secretion and its suppression on skeletal growth and maturation. Pubertal growth velocity (GV) was 10.1 +/- 0.7 (SE) cm/yr and, when normalized for chronological age (CA) and bone age (BA), demonstrated that the effects of sex steroids were most profound in patients with the youngest CA and BA. GV decreased significantly to 5.8 +/- 0.3 (n = 40), 4.6 +/- 0.3 (n = 30), and 3.2 +/- 0.6 cm/yr (n = 12) during 3 yr of gonadal suppression and correlated negatively with starting BA. Skeletal maturation was markedly accelerated by premature sex steroid secretion (BA/CA = 1.8 +/- 0.1), was slowed significantly with gonadal suppression (mean delta BA/delta CA less than 1), and also was negatively correlated with the starting BA. Cumulative increases in predicted adult height were observed regardless of starting BA and averaged +2.0 +/- 0.4, +5.2 +/- 0.5, and +6.7 +/- 1.2 cm after 1, 2, and 3 yr of gonadal suppression. The comparable changes in height predictions across all BAs despite highly variable GVs underscore the need for use of developmental (i.e., BA-based) rather than CA-based standards in the analysis of growth during gonadal steroid exposure and suppression in childhood.

摘要

对40名中枢性性早熟(CPP)女孩在使用促黄体生成激素释放因子(LHRH)激动剂(LHRHa)治疗前及治疗1 - 3年期间进行了研究,以检查性腺类固醇分泌及其抑制对骨骼生长和成熟的影响。青春期生长速度(GV)为10.1±0.7(标准误)cm/年,按实足年龄(CA)和骨龄(BA)进行标准化后发现,性类固醇对CA和BA最小的患者影响最为显著。在性腺抑制的3年期间,GV显著下降至5.8±0.3(n = 40)、4.6±0.3(n = 30)和3.2±0.6 cm/年(n = 12),且与起始骨龄呈负相关。过早的性类固醇分泌使骨骼成熟明显加速(BA/CA = 1.8±0.1),性腺抑制时显著减缓(平均BA变化/CA变化小于1),也与起始骨龄呈负相关。无论起始骨龄如何,在性腺抑制1、2和3年后均观察到预测成年身高的累积增加,平均分别增加2.0±0.4、5.2±0.5和6.7±1.2 cm。尽管GV高度可变,但所有骨龄的身高预测变化具有可比性,这突出表明在分析儿童性腺类固醇暴露和抑制期间的生长时,需要使用基于发育(即基于骨龄)而非基于实足年龄的标准。

相似文献

1
Impact of sex steroids and their suppression on skeletal growth and maturation.性类固醇及其抑制对骨骼生长和成熟的影响。
Am J Physiol. 1988 Oct;255(4 Pt 1):E559-66. doi: 10.1152/ajpendo.1988.255.4.E559.
2
Changes in growth and serum growth hormone and plasma somatomedin-C levels during suppression of gonadal sex steroid secretion in girls with central precocious puberty.中枢性性早熟女童性腺甾体激素分泌受抑制期间生长及血清生长激素和血浆生长调节素C水平的变化
J Clin Endocrinol Metab. 1988 Jan;66(1):3-9. doi: 10.1210/jcem-66-1-3.
3
Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.使用促性腺激素释放激素的强效长效激动剂治疗性早熟。
Endocr Rev. 1986 Feb;7(1):24-33. doi: 10.1210/edrv-7-1-24.
4
Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty.中枢性性早熟长期使用促黄体生成素释放激素激动剂治疗后青春期的恢复
J Clin Endocrinol Metab. 1988 Aug;67(2):368-72. doi: 10.1210/jcem-67-2-368.
5
Adrenarche and skeletal maturation during luteinizing hormone releasing hormone analogue suppression of gonadarche.促性腺激素释放激素类似物抑制青春期时的肾上腺功能初现和骨骼成熟。
J Clin Invest. 1986 Jan;77(1):121-6. doi: 10.1172/JCI112265.
6
Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.用强效促黄体生成素释放因子激动剂治疗真性性早熟:对生长、性成熟、盆腔超声检查及下丘脑-垂体-性腺轴的影响。
J Clin Endocrinol Metab. 1985 Jul;61(1):142-51. doi: 10.1210/jcem-61-1-142.
7
Gonadotrophin-releasing hormone agonist treatment of central precocious puberty: an analysis of growth data in a developmental context.
Acta Paediatr Scand Suppl. 1990;367:38-43. doi: 10.1111/j.1651-2227.1990.tb11630.x.
8
Gonadotrophin-releasing hormone analogues as therapeutic probes in human growth and development: evidence from children with central precocious puberty.
Acta Paediatr Scand Suppl. 1991;372:33-8. doi: 10.1111/j.1651-2227.1991.tb17966.x.
9
Luteinizing hormone releasing hormone analogue therapy for central precocious puberty. Long-term effect on somatic growth, bone maturation, and predicted height.促黄体生成素释放激素类似物治疗中枢性性早熟。对身体生长、骨骼成熟及预测身高的长期影响。
JAMA. 1986 May 16;255(19):2613-6.
10
Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist.正常青春期及真性性早熟患者在使用强效促黄体生成素释放激素激动剂治疗前后的生长调节素C
J Clin Endocrinol Metab. 1985 Jul;61(1):152-9. doi: 10.1210/jcem-61-1-152.

引用本文的文献

1
Clinical features of congenital adrenal insufficiency including growth patterns and significance of ACTH stimulation test.先天性肾上腺皮质功能减退症的临床特征,包括生长模式和促肾上腺皮质激素刺激试验的意义。
J Korean Med Sci. 2013 Nov;28(11):1650-6. doi: 10.3346/jkms.2013.28.11.1650. Epub 2013 Oct 31.
2
Longitudinal analysis of growth and puberty in 21-hydroxylase deficiency patients.21-羟化酶缺乏症患者生长与青春期的纵向分析
Arch Dis Child. 2002 Aug;87(2):139-44. doi: 10.1136/adc.87.2.139.
3
Histrelin. A review of its pharmacological properties and therapeutic role in central precocious puberty.
组氨瑞林。其药理特性及在中枢性性早熟治疗作用的综述
Drugs. 1993 Apr;45(4):570-88. doi: 10.2165/00003495-199345040-00008.